Registered Representatives of Kestra IS and Investment Advisor Representatives of Kestra PWS may only conduct business with residents of the states and jurisdictions in which they are properly registered
Combining BPC-157 (10 mg), GHK-Cu (50 mg), and TB500 (10 mg), this proprietary Glow Blend brings together three regenerative peptides in a carefully balanced ratio designed to support experimental work focused on structural repair, cellular signaling, angiogenesis, and extracellular matrix remodeling
Initiation injections (cabotegravir 600 mg/3 mL and rilpivirine 900 mg/3 mL) should be administered on the last day of oral lead-in, if used Every-2-month dosing schedule 2 IM injections at separate gluteal sites (opposite sides or at least 2 cm apart) during same visit Initiate injections on the last day of current antiretroviral therapy or oral lead-in, if used
Sermorelin tends to have fewer systemic side effects than exogenous GH, but localized and hormonal reactions can still occur in sensitive individuals. Merriam et al., Clinical Endocrinology Common Side Effects Injection site irritation (redness, swelling, or discomfort) Headaches and dizziness Temporary water retention or puffiness Nausea or lightheadedness shortly after dosing Flu-like symptoms (rare, typically early in treatment) Less Common But Notable Risks Carpal tunnel symptoms (numbness/tingling in hands) Mood changes or mild anxiety due to elevated cortisol Gynecomastia (in rare cases with high GH/IGF-1 over time) Insulin sensitivity changes with prolonged or stacked use Mitigation Tips Start with lower doses and titrate slowly Rotate injection sites to prevent irritation Avoid late-night meals high in carbs or fat , which can blunt GH spikes Consider cycling off after 812 weeks to restore baseline sensitivity If youre stacking Sermorelin with other peptides like Ipamorelin or MK-677 , be mindful of synergistic effects on appetite, cortisol, or water retention
These insights help researchers better understand how selective peptide signaling contributes to efficient energy regulation without broader endocrine activation
